Obinutuzumab is an anti-CD20 monoclonal antibody, combined with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia, in combination with bendamustis in the treatment of follicular lymphoma after failure of a rituximab-containing regimen.

Antigens are simply understood as substances that, when entering the human body, will be quickly recognized by the immune system and produce corresponding antibodies to specifically combine with that antigen. Usually, antigens are a protein, a polysaccharide, but can also be any type of molecule carrying small haptens attached to a carrier protein.

The immune system is essential for life, without the immune system, the body would be vulnerable to attack by bacteria, viruses, parasites, etc. The immune system keeps us healthy when exposed to pathogens. The immune system is located throughout the body and involves many types of cells, organs, proteins and tissues. It is important that the immune system can distinguish the body's own tissue from foreign tissue. Dead or damaged cells are also recognized and eliminated by the immune system.

B and T lymphocytes play an important role in the body's immune system. These cells are made in the bone marrow and circulate in the blood and lymph tissues. These cells work together to protect the body against foreign organisms, such as bacteria, viruses, and cancer cells.

Tafasitamab-cxix or Monjuvi is a prescription medicine used to treat diffuse large B-cell lymphoma (DLBCL), a type of non-hodgkin lymphoma. Tafasitamab-cxix should only be used as ordered and directed by your doctor. Do not arbitrarily use to avoid encountering risks.